Skip to main content

Advertisement

SpringerLink
Log in

Overexpression of Claudin-1 is Associated with Advanced Clinical Stage and Invasive Pathologic Characteristics of Oral Squamous Cell Carcinoma

  • Original Paper
  • Published:
Head and Neck Pathology Aims and scope Submit manuscript

Abstract

Claudins constitute a group of principal proteins forming the tight junctional complex. The altered expression of selected claudins has been reported in several human cancers. The purpose of this study was to investigate the expression of claudin-1 and claudin-4 in oral squamous cell carcinoma (OSCC) and examine its relationship with patient clinical-pathologic features. Forty-five OSCC cases were enrolled. Patient clinical, pathologic and follow-up data were reviewed and the claudin-1 and claudin-4 expression was analyzed immunohistochemically. Positive claudin-1 and claudin-4 immunoreactivities were noted in 86.7 and 80 % of cases, respectively. The majority of cases showed the staining in less than 25 % of cancer cells. The increased claudin-1 expression was significantly associated with the high pathologic grade, the presence of microscopic perineural invasion, vascular invasion, nodal metastasis, and advanced clinical stage. No relationship between various clinico-pathologic parameters and differential claudin-4 expression was observed. Claudin-1 may play a role in OSCC progression and could serve as a prognostic marker of advanced disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Johnson NW, Jayasekara P, Amarasinghe AA. Squamous cell carcinoma and precursor lesions of the oral cavity: epidemiology and aetiology. Periodontology 2000. 2011;57(1):19–37. doi:10.1111/j.1600-0757.2011.00401.x.

  2. Massano J, Regateiro FS, Januario G, Ferreira A. Oral squamous cell carcinoma: review of prognostic and predictive factors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;102(1):67–76. doi:10.1016/j.tripleo.2005.07.038.

    Article  PubMed  Google Scholar 

  3. Schneeberger EE, Lynch RD. The tight junction: a multifunctional complex. Am J Physiol Cell Physiol. 2004;286(6):C1213–28. doi:10.1152/ajpcell.00558.2003.

    Article  CAS  PubMed  Google Scholar 

  4. Tsukita S, Yamazaki Y, Katsuno T, Tamura A. Tight junction-based epithelial microenvironment and cell proliferation. Oncogene. 2008;27(55):6930–8. doi:10.1038/onc.2008.344.

    Article  CAS  PubMed  Google Scholar 

  5. Hewitt KJ, Agarwal R, Morin PJ. The claudin gene family: expression in normal and neoplastic tissues. BMC Cancer. 2006;6:186. doi:10.1186/1471-2407-6-186.

    Article  PubMed Central  PubMed  Google Scholar 

  6. Krause G, Winkler L, Mueller SL, Haseloff RF, Piontek J, Blasig IE. Structure and function of claudins. Biochim Biophys Acta. 2008;1778(3):631–45. doi:10.1016/j.bbamem.2007.10.018.

    Article  CAS  PubMed  Google Scholar 

  7. Yuki T, Haratake A, Koishikawa H, Morita K, Miyachi Y, Inoue S. Tight junction proteins in keratinocytes: localization and contribution to barrier function. Exp Dermatol. 2007;16(4):324–30. doi:10.1111/j.1600-0625.2006.00539.x.

    Article  CAS  PubMed  Google Scholar 

  8. Oliveira SS, Morgado-Diaz JA. Claudins: multifunctional players in epithelial tight junctions and their role in cancer. Cell Mol Life Sci. 2007;64(1):17–28. doi:10.1007/s00018-006-6314-1.

    Article  CAS  PubMed  Google Scholar 

  9. Morin PJ. Claudin proteins in human cancer: promising new targets for diagnosis and therapy. Cancer Res. 2005;65(21):9603–6. doi:10.1158/0008-5472.CAN-05-2782.

    Article  CAS  PubMed  Google Scholar 

  10. Morohashi S, Kusumi T, Sato F, Odagiri H, Chiba H, Yoshihara S, et al. Decreased expression of claudin-1 correlates with recurrence status in breast cancer. Int J Mol Med. 2007;20(2):139–43.

    PubMed  Google Scholar 

  11. Seo KW, Kwon YK, Kim BH, Kim CI, Chang HS, Choe MS, et al. Correlation between claudins expression and prognostic factors in prostate cancer. Korean J Urol. 2010;51(4):239–44. doi:10.4111/kju.2010.51.4.239.

    Article  PubMed Central  PubMed  Google Scholar 

  12. Szasz AM, Tokes AM, Micsinai M, Krenacs T, Jakab C, Lukacs L, et al. Prognostic significance of claudin expression changes in breast cancer with regional lymph node metastasis. Clin Exp Metastasis. 2011;28(1):55–63. doi:10.1007/s10585-010-9357-5.

    Article  CAS  PubMed  Google Scholar 

  13. Lee JW, Lee SJ, Seo J, Song SY, Ahn G, Park CS, et al. Increased expressions of claudin-1 and claudin-7 during the progression of cervical neoplasia. Gynecol Oncol. 2005;97(1):53–9. doi:10.1016/j.ygyno.2004.11.058.

    Article  CAS  PubMed  Google Scholar 

  14. Nakanishi K, Ogata S, Hiroi S, Tominaga S, Aida S, Kawai T. Expression of occludin and claudins 1, 3, 4, and 7 in urothelial carcinoma of the upper urinary tract. Am J Clin Pathol. 2008;130(1):43–9. doi:10.1309/U77A6BTEXVCA5D0E.

    Article  PubMed  Google Scholar 

  15. Resnick MB, Gavilanez M, Newton E, Konkin T, Bhattacharya B, Britt DE, et al. Claudin expression in gastric adenocarcinomas: a tissue microarray study with prognostic correlation. Hum Pathol. 2005;36(8):886–92. doi:10.1016/j.humpath.2005.05.019.

    Article  CAS  PubMed  Google Scholar 

  16. Sobel G, Paska C, Szabo I, Kiss A, Kadar A, Schaff Z. Increased expression of claudins in cervical squamous intraepithelial neoplasia and invasive carcinoma. Hum Pathol. 2005;36(2):162–9. doi:10.1016/j.humpath.2004.12.001.

    Article  CAS  PubMed  Google Scholar 

  17. Lee LY, Wu CM, Wang CC, Yu JS, Liang Y, Huang KH, et al. Expression of matrix metalloproteinases MMP-2 and MMP-9 in gastric cancer and their relation to claudin-4 expression. Histol Histopathol. 2008;23(5):515–21.

    PubMed  Google Scholar 

  18. Nichols LS, Ashfaq R, Iacobuzio-Donahue CA. Claudin 4 protein expression in primary and metastatic pancreatic cancer: support for use as a therapeutic target. Am J Clin Pathol. 2004;121(2):226–30. doi:10.1309/K144-PHVD-DUPD-D401.

    Article  CAS  PubMed  Google Scholar 

  19. Hwang TL, Lee LY, Wang CC, Liang Y, Huang SF, Wu CM. Claudin-4 expression is associated with tumor invasion, MMP-2 and MMP-9 expression in gastric cancer. Exp Ther Med. 2010;1(5):789–97. doi:10.3892/etm.2010.116.

    PubMed Central  PubMed  Google Scholar 

  20. Pan XY, Li X, Che YC, Li HY, Zhang Y, Yang X. Overexpression of claudin-4 may be involved in endometrial tumorigenesis. Oncol Lett. 2013;5(4):1422–6. doi:10.3892/ol.2013.1198.

    PubMed Central  CAS  PubMed  Google Scholar 

  21. Szekely E, Torzsok P, Riesz P, Korompay A, Fintha A, Szekely T, et al. Expression of claudins and their prognostic significance in noninvasive urothelial neoplasms of the human urinary bladder. J Histochem Cytochem. 2011;59(10):932–41. doi:10.1369/0022155411418829.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  22. Tsutsumi K, Sato N, Tanabe R, Mizumoto K, Morimatsu K, Kayashima T, et al. Claudin-4 expression predicts survival in pancreatic ductal adenocarcinoma. Ann Surg Oncol. 2012;19(Suppl 3):S491–9. doi:10.1245/s10434-011-1970-2.

    Article  PubMed  Google Scholar 

  23. Zhu JL, Gao P, Wang ZN, Song YX, Li AL, Xu YY, et al. Clinicopathological significance of claudin-4 in gastric carcinoma. World J Surg Oncol. 2013;11:150. doi:10.1186/1477-7819-11-150.

    Article  PubMed Central  PubMed  Google Scholar 

  24. Shang X, Lin X, Alvarez E, Manorek G, Howell SB. Tight junction proteins claudin-3 and claudin-4 control tumor growth and metastases. Neoplasia. 2012;14(10):974–85.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  25. Bello IO, Vilen ST, Niinimaa A, Kantola S, Soini Y, Salo T. Expression of claudins 1, 4, 5, and 7 and occludin, and relationship with prognosis in squamous cell carcinoma of the tongue. Hum Pathol. 2008;39(8):1212–20. doi:10.1016/j.humpath.2007.12.015.

    Article  CAS  PubMed  Google Scholar 

  26. Carvalho Mde V, Pereira Jdos S, Costa Ade L, de Souza LB, Freitas Rde A, Miguel MC. Alterations in the immunoexpression of claudin-1 between different grades of oral epithelial dysplasias. Arch Oral Biol. 2010;55(4):261–7. doi:10.1016/j.archoralbio.2010.02.001.

  27. de Aquino AR, de Carvalho CH, Nonaka CF, de Freitas RA, de Souza LB, Pinto LP. Immunoexpression of claudin-1 and Nm23-H1 in metastatic and nonmetastatic lower lip squamous-cell carcinoma. Appl Immunohistochem Mol Morphol. 2012;20(6):595–601. doi:10.1097/PAI.0b013e3182505c22.

    Article  PubMed  Google Scholar 

  28. Lourenco SV, Coutinho-Camillo CM, Buim ME, de Carvalho AC, Lessa RC, Pereira CM, et al. Claudin-7 down-regulation is an important feature in oral squamous cell carcinoma. Histopathology. 2010;57(5):689–98. doi:10.1111/j.1365-2559.2010.03685.x.

    Article  PubMed  Google Scholar 

  29. Melchers LJ, Bruine de Bruin L, Schnell U, Slagter-Menkema L, Mastik MF, de Bock GH et al. Lack of claudin-7 is a strong predictor of regional recurrence in oral and oropharyngeal squamous cell carcinoma. Oral Oncol. 2013;49(10):998–1005. doi:10.1016/j.oraloncology.2013.07.008.

  30. Ouban A, Hamdan H, Hakam A, Ahmed AA. Claudin-1 expression in squamous cell carcinomas of different organs: comparative study of cancerous tissues and normal controls. Int J Surg Pathol. 2012;20(2):132–8. doi:10.1177/1066896911424488.

    PubMed  Google Scholar 

  31. Lourenco SV, Coutinho-Camillo CM, Buim ME, Pereira CM, Carvalho AL, Kowalski LP, et al. Oral squamous cell carcinoma: status of tight junction claudins in the different histopathological patterns and relationship with clinical parameters. A tissue-microarray-based study of 136 cases. J Clin Pathol. 2010;63(7):609–14. doi:10.1136/jcp.2009.070409.

    Article  PubMed  Google Scholar 

  32. Dhawan P, Singh AB, Deane NG, No Y, Shiou SR, Schmidt C, et al. Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer. J Clin Invest. 2005;115(7):1765–76. doi:10.1172/JCI24543.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  33. Dos Reis PP, Bharadwaj RR, Machado J, Macmillan C, Pintilie M, Sukhai MA, et al. Claudin 1 overexpression increases invasion and is associated with aggressive histological features in oral squamous cell carcinoma. Cancer. 2008;113(11):3169–80. doi:10.1002/cncr.23934.

    Article  PubMed  Google Scholar 

  34. Oku N, Sasabe E, Ueta E, Yamamoto T, Osaki T. Tight junction protein claudin-1 enhances the invasive activity of oral squamous cell carcinoma cells by promoting cleavage of laminin-5 gamma2 chain via matrix metalloproteinase (MMP)-2 and membrane-type MMP-1. Cancer Res. 2006;66(10):5251–7. doi:10.1158/0008-5472.CAN-05-4478.

    Article  CAS  PubMed  Google Scholar 

  35. Miyamori H, Takino T, Kobayashi Y, Tokai H, Itoh Y, Seiki M, et al. Claudin promotes activation of pro-matrix metalloproteinase-2 mediated by membrane-type matrix metalloproteinases. J Biol Chem. 2001;276(30):28204–11. doi:10.1074/jbc.M103083200.

    Article  CAS  PubMed  Google Scholar 

  36. Agarwal R, D’Souza T, Morin PJ. Claudin-3 and claudin-4 expression in ovarian epithelial cells enhances invasion and is associated with increased matrix metalloproteinase-2 activity. Cancer Res. 2005;65(16):7378–85. doi:10.1158/0008-5472.CAN-05-1036.

    Article  CAS  PubMed  Google Scholar 

  37. Konecny GE, Agarwal R, Keeney GA, Winterhoff B, Jones MB, Mariani A, et al. Claudin-3 and claudin-4 expression in serous papillary, clear-cell, and endometrioid endometrial cancer. Gynecol Oncol. 2008;109(2):263–9. doi:10.1016/j.ygyno.2008.01.024.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  38. Akervall J, Nandalur S, Zhang J, Qian CN, Goldstein N, Gyllerup P, et al. A novel panel of biomarkers predicts radioresistance in patients with squamous cell carcinoma of the head and neck. Eur J Cancer. 2014;50(3):570–81. doi:10.1016/j.ejca.2013.11.007.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Faculty of Dental Medicine, Rangsit University, 52/347 Muang-Ake, Phaholyothin Road, Lak-Hok, Muang, Pathumthani, 12000, Thailand

    Kraisorn Sappayatosok

  2. Department of Oral Pathology, Faculty of Dentistry, Chulalongkorn University, Henri-Dunant Road, Pathumwan, Bangkok, 10330, Thailand

    Ekarat Phattarataratip

Authors
  1. Kraisorn Sappayatosok
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ekarat Phattarataratip
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ekarat Phattarataratip.

Additional information

Disclosures This study was funded by a Research Fund, Faculty of Dental Medicine, Rangsit University. All authors disclose no commercial associations or financial interest that might pose a conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sappayatosok, K., Phattarataratip, E. Overexpression of Claudin-1 is Associated with Advanced Clinical Stage and Invasive Pathologic Characteristics of Oral Squamous Cell Carcinoma. Head and Neck Pathol 9, 173–180 (2015). https://doi.org/10.1007/s12105-014-0559-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12105-014-0559-z

Keywords

Search

Navigation